- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/08 - Monoclonal antibodies
Patent holdings for IPC class C12P 21/08
Total number of patents in this class: 4096
10-year publication summary
282
|
178
|
201
|
175
|
238
|
205
|
142
|
108
|
69
|
44
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Chugai Seiyaku Kabushiki Kaisha | 1349 |
134 |
Daiichi Sankyo Company, Limited | 1865 |
68 |
Genentech, Inc. | 3975 |
61 |
Amgen Inc. | 4074 |
54 |
Regeneron Pharmaceuticals, Inc. | 4246 |
54 |
F. Hoffmann-La Roche AG | 7929 |
50 |
Kyowa Hakko Kirin Co., Ltd. | 280 |
43 |
The Regents of the University of California | 19868 |
40 |
Toray Industries, Inc. | 6931 |
40 |
Kyowa Kirin Co., Ltd. | 368 |
37 |
Xencor, Inc. | 396 |
36 |
Astellas Pharma Inc. | 1087 |
34 |
Osaka University | 3374 |
34 |
MedImmune, LLC | 492 |
33 |
The University of Tokyo | 4168 |
33 |
Abbvie Inc. | 1803 |
30 |
Janssen Biotech, Inc. | 1546 |
29 |
Novartis AG | 10867 |
26 |
FUJIFILM Corporation | 29305 |
23 |
Pfizer Inc. | 3379 |
21 |
Other owners | 3216 |